Comparison of the Effects of Haloperidol and Dexmedetomidine on Delirium and Agitation in Patients with a Traumatic Brain Injury Admitted to the Intensive Care Unit.
Delirium
Dexmedetomidine
Haloperidol
ICU
Traumatic Brain Injury
Journal
Anesthesiology and pain medicine
ISSN: 2228-7523
Titre abrégé: Anesth Pain Med
Pays: Netherlands
ID NLM: 101585412
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
18
02
2021
revised:
27
04
2021
accepted:
18
05
2021
entrez:
20
9
2021
pubmed:
21
9
2021
medline:
21
9
2021
Statut:
epublish
Résumé
Patients under mechanical ventilation in the Intensive Care Unit (ICU) have a higher risk of delirium. To date, the ideal sedative combination for delirium treatment in terms of cost and side effects has not been determined. This study was designed to compare the effects of haloperidol and dexmedetomidine on delirium in trauma patients under mechanical ventilation in the ICU. Sixty patients with a moderate traumatic brain injury were randomly divided into two groups. Patients in the haloperidol group received 2.5 mg of haloperidol intravenously every eight hours for ten minutes daily, and the dexmedetomidine group received 0.5 µg/kg of dexmedetomidine via intravenous infusion every other day. Delirium, agitation, length of hospitalization, duration of mechanical ventilation, and need for sedation up to seven days were measured and recorded in both groups. The Richmond Agitation-Sedation scale (RASS) and Acute Physiology and Chronic Health evaluation (APACHE II) scales were used to determine the level of agitation in patients. The Confusion Assessment method (CAM)-ICU criteria were used to determine the incidence of delirium. Based on the results of this study, age and sex of the two groups were not significantly different. The mean age of the patients was 36.83 years in the haloperidol group and 40.1 years in the dexmedetomidine group. After the intervention, there was no significant difference in terms of the level of consciousness, number of days required for ventilation (P = 0.17), and number of days in the ICU (P = 0.49); however, there was a significant difference between the two groups three to seven days after the intervention. Besides, there was a significant difference between the two groups regarding the incidence of delirium five to seven days after the intervention (P < 0.05). There was a significant difference between the two groups in terms of the incidence of delirium and the level of agitation; the patients in the dexmedetomidine group were calmer and experienced less delirium.
Sections du résumé
BACKGROUND
BACKGROUND
Patients under mechanical ventilation in the Intensive Care Unit (ICU) have a higher risk of delirium. To date, the ideal sedative combination for delirium treatment in terms of cost and side effects has not been determined.
OBJECTIVES
OBJECTIVE
This study was designed to compare the effects of haloperidol and dexmedetomidine on delirium in trauma patients under mechanical ventilation in the ICU.
METHODS
METHODS
Sixty patients with a moderate traumatic brain injury were randomly divided into two groups. Patients in the haloperidol group received 2.5 mg of haloperidol intravenously every eight hours for ten minutes daily, and the dexmedetomidine group received 0.5 µg/kg of dexmedetomidine via intravenous infusion every other day. Delirium, agitation, length of hospitalization, duration of mechanical ventilation, and need for sedation up to seven days were measured and recorded in both groups. The Richmond Agitation-Sedation scale (RASS) and Acute Physiology and Chronic Health evaluation (APACHE II) scales were used to determine the level of agitation in patients. The Confusion Assessment method (CAM)-ICU criteria were used to determine the incidence of delirium.
RESULTS
RESULTS
Based on the results of this study, age and sex of the two groups were not significantly different. The mean age of the patients was 36.83 years in the haloperidol group and 40.1 years in the dexmedetomidine group. After the intervention, there was no significant difference in terms of the level of consciousness, number of days required for ventilation (P = 0.17), and number of days in the ICU (P = 0.49); however, there was a significant difference between the two groups three to seven days after the intervention. Besides, there was a significant difference between the two groups regarding the incidence of delirium five to seven days after the intervention (P < 0.05).
CONCLUSIONS
CONCLUSIONS
There was a significant difference between the two groups in terms of the incidence of delirium and the level of agitation; the patients in the dexmedetomidine group were calmer and experienced less delirium.
Identifiants
pubmed: 34540634
doi: 10.5812/aapm.113802
pmc: PMC8438711
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e113802Informations de copyright
Copyright © 2021, Author(s).
Déclaration de conflit d'intérêts
Conflict of Interests: There was no conflict of interest.
Références
Crit Care Med. 2013 Sep;41(9 Suppl 1):S99-115
pubmed: 23989099
Crit Care Med. 2016 Jul;44(7):1295-306
pubmed: 26925523
Anesth Pain Med. 2020 Aug 26;10(4):e106076
pubmed: 33134152
Anesth Pain Med. 2019 Apr 28;9(2):e90858
pubmed: 31341829
Anesth Pain Med. 2020 Aug 08;10(4):e101815
pubmed: 33134142
Ann Intensive Care. 2018 Sep 20;8(1):92
pubmed: 30238227
Crit Care. 2009;13(3):R75
pubmed: 19454032
Anesth Pain Med. 2021 Jan 02;10(6):e112176
pubmed: 34150582
Behav Brain Res. 2012 Apr 1;229(1):153-9
pubmed: 22244923
Crit Care Med. 2016 Dec;44(12):e1259-e1260
pubmed: 27858832
Biomed Res Int. 2015;2015:635737
pubmed: 26576429
J Am Geriatr Soc. 2005 Oct;53(10):1658-66
pubmed: 16181163
Anesth Pain Med. 2020 Feb 12;10(1):e95287
pubmed: 32309196
JAMA. 2016 Apr 12;315(14):1460-8
pubmed: 26975647
Anesth Pain Med. 2018 Nov 21;8(6):e81077
pubmed: 30719412
Trials. 2018 Jun 4;19(1):307
pubmed: 29866205
Anesth Pain Med. 2018 Apr 28;8(2):e66959
pubmed: 30009153
Anesth Pain Med. 2019 Feb 26;9(1):e86442
pubmed: 30881913
Drugs. 2015 Jul;75(10):1119-30
pubmed: 26063213
Surg Today. 2014 Dec;44(12):2305-13
pubmed: 24532143
Anesthesiology. 2019 Aug;131(2):328-335
pubmed: 31246603
J Cardiothorac Vasc Anesth. 2014 Dec;28(6):1459-66
pubmed: 25034724
Lancet Respir Med. 2013 Sep;1(7):515-23
pubmed: 24461612
Am J Crit Care. 2012 Jan;21(1):e12-20
pubmed: 22210705